Evergreen Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$335K Sell
1,198
-132
-10% -$34.7K 0.01% 1147
2026
Q1
$355K Buy
1,330
+131
+11% +$35.5K 0.01% 1002
2025
Q4
$301K Buy
1,199
+172
+17% +$45.7K 0.01% 1033
2025
Q3
$295K Sell
1,027
-166
-14% -$44.5K 0.01% 988
2025
Q2
$313K Buy
1,193
+91
+8% +$22.2K 0.01% 779
2025
Q1
$256K Sell
1,102
-101
-8% -$24.5K 0.01% 845
2024
Q4
$276K Buy
1,203
+4
+0.3% +$918 0.01% 782
2024
Q3
$268K Sell
1,199
-14
-1% -$3.08K 0.01% 767
2024
Q2
$247K Buy
+1,213
New +$247K 0.01% 743
2023
Q2
Sell
-1,232
Closed -$243K 823
2023
Q1
$243K Buy
+1,232
New +$254K 0.01% 589

Other funds holding LH

Evergreen Capital Management's LH Position: Q2 2026 in Review

Evergreen Capital Management reduced its Labcorp (LH) stake by 9.9% in Q2 2026, selling an estimated $34.7K and leaving 1,198 shares worth $335K. The position accounts for 0.01% of the portfolio, ranked #1147.

Evergreen Capital Management first reported a position in LH in Q1 2023 and has held it in 10 quarters since. The position peaked at $355K in Q1 2026. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Evergreen Capital Management held 1,198 shares of Labcorp worth $335K as of Q2 2026.
  • Evergreen Capital Management sold 132 Labcorp shares in Q2 2026, an estimated $34.7K.
  • Labcorp made up 0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #1147 holding.
  • Evergreen Capital Management first reported a position in Labcorp in Q1 2023 and has held it in 10 quarters since.
  • Evergreen Capital Management's Labcorp position peaked at $355K in Q1 2026.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.